Quarterly report [Sections 13 or 15(d)]

Interim Condensed Consolidated Statements of Changes in Shareholders' Equity

v3.26.1
Interim Condensed Consolidated Statements of Changes in Shareholders' Equity - USD ($)
$ in Thousands
Share Capital
Contributed Surplus
Accumulated Other Comprehensive Income
Accumulated Deficit
Total
Beginning Balance at Dec. 31, 2024 $ 413,242 $ 19,468 $ 4,189 $ (304,100) $ 132,799
Beginning Balance (in shares) at Dec. 31, 2024 364,101,038        
Exercise of stock options $ 405 213     618
Exercise of stock options (in shares) 464,807        
Redemption of RSUs $ 283 (343)     (60)
Redemption of RSUs (in shares) 253,415        
Stock compensation   668     668
Net income (loss)     (28) (10,898) (10,926)
Ending Balance at Mar. 31, 2025 $ 413,930 20,006 4,161 (314,998) 123,099
Ending Balance (in shares) at Mar. 31, 2025 364,819,260        
Beginning Balance at Dec. 31, 2025 $ 432,761 19,645 4,044 (378,998) 77,452
Beginning Balance (in shares) at Dec. 31, 2025 378,169,709        
Exercise of warrants $ 33,031       33,031
Exercise of warrants (in shares) 19,129,999        
Exercise of stock options $ 65       $ 65
Exercise of stock options (in shares) 32,145       32,145
Redemption of RSUs   (35)     $ (35)
Stock compensation   224     224
Net income (loss)     914 (28,775) (27,861)
Ending Balance at Mar. 31, 2026 $ 465,857 $ 19,834 $ 4,958 $ (407,773) $ 82,876
Ending Balance (in shares) at Mar. 31, 2026 397,331,853